These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1352246)

  • 1. Neuroendocrine effects of ipsapirone on the hypothalamic-pituitary adrenal axis: CRF, ACTH and cortisol in healthy volunteers.
    Beneke M; Wingender W; Horstmann R; Konrad-Dalhoff I; Weber H; Kuhlmann J; Schmidt BH
    Eur J Clin Pharmacol; 1992; 42(2):163-9. PubMed ID: 1352246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients.
    Clark DJ; Lipworth BJ
    Chest; 1997 Nov; 112(5):1248-52. PubMed ID: 9367464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of pituitary and adrenocortical suppression after long-term administration of anti-inflammatory doses of prednisone in dogs.
    Moore GE; Hoenig M
    Am J Vet Res; 1992 May; 53(5):716-20. PubMed ID: 1326243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acute effects of oral ethanol on the hypothalamic-pituitary-adrenal axis in normal human subjects.
    Inder WJ; Joyce PR; Wells JE; Evans MJ; Ellis MJ; Mattioli L; Donald RA
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):65-71. PubMed ID: 7889634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
    Schwartz PJ; Turner EH; Garcia-Borreguero D; Sedway J; Vetticad RG; Wehr TA; Murphy DL; Rosenthal NE
    Psychiatry Res; 1999 Apr; 86(1):9-28. PubMed ID: 10359479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog].
    Inoue T; Inui A; Okita M; Sakatani N; Oya M; Morioka H; Mizuno N; Oimomi M; Baba S
    Nihon Naibunpi Gakkai Zasshi; 1990 Jun; 66(6):607-18. PubMed ID: 2167247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog.
    Inoue T; Inui A; Okita M; Sakatani N; Oya M; Morioka H; Mizuno N; Oimomi M; Baba S
    Life Sci; 1989; 44(15):1043-51. PubMed ID: 2538698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):421-3. PubMed ID: 9171947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
    Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson AJ; Jackson RV
    J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep and hypothalamic pituitary adrenal axis responses to metyrapone in posttraumatic stress disorder.
    Inslicht SS; Rao MN; Richards A; O'Donovan A; Gibson CJ; Baum T; Metzler TJ; Neylan TC
    Psychoneuroendocrinology; 2018 Feb; 88():136-143. PubMed ID: 29268182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain.
    Owens MJ; Edwards E; Nemeroff CB
    Eur J Pharmacol; 1990 Nov; 190(1-2):113-22. PubMed ID: 1963847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical note: effect of corticotropin-releasing hormone on adrenocorticotropic hormone and cortisol in steers.
    Gupta S; Earley B; Ting ST; Leonard N; Crowe MA
    J Anim Sci; 2004 Jul; 82(7):1952-6. PubMed ID: 15309941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine response to CRF stimulation in veterans with and without PTSD in consideration of war zone era.
    Golier JA; Caramanica K; Yehuda R
    Psychoneuroendocrinology; 2012 Mar; 37(3):350-7. PubMed ID: 21813244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls.
    Lesch KP; Mayer S; Disselkamp-Tietze J; Hoh A; Wiesmann M; Osterheider M; Schulte HM
    Biol Psychiatry; 1990 Oct; 28(7):620-8. PubMed ID: 1977479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress.
    Pasquali R; Anconetani B; Chattat R; Biscotti M; Spinucci G; Casimirri F; Vicennati V; Carcello A; Labate AM
    Metabolism; 1996 Mar; 45(3):351-6. PubMed ID: 8606643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects.
    Berlin I; Warot D; Legout V; Guillemant S; Schöllnhammer G; Puech AJ
    Clin Pharmacol Ther; 1998 Apr; 63(4):428-36. PubMed ID: 9585797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of naproxen on the hypothalamic-pituitary-adrenal axis in healthy volunteers.
    Eijsbouts AM; Kempers MJ; Kramer RS; Hopman MT; van den Hoogen FH; Laan RF; Hermus AR; Sweep FC; van de Putte LB
    Br J Clin Pharmacol; 2009 Jan; 67(1):22-8. PubMed ID: 19133058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.